Exhibit 99.3

 

 

LOGO

NUTRIEN LTD.

INTERIM FINANCIAL STATEMENTS AND NOTES

AS AT AND FOR THE THREE AND SIX MONTHS ENDED

JUNE 30, 2026


Unaudited

 

Condensed Consolidated Financial Statements

Condensed Consolidated Statements of Earnings

 

         

Three Months Ended
June 30

   

Six Months Ended
June 30

 
 ($ millions, except as otherwise noted)   Note     2026     2025     2026     2025  

Sales

    2, 8       10,812       10,438       16,858       15,538  

Freight, transportation and distribution

      203       240       447       466  

Cost of goods sold

            7,358       7,023       11,514       10,577  

Gross Margin

      3,251       3,175       4,897       4,495  

Selling expenses

      1,001       951       1,800       1,708  

General and administrative expenses

      169       148       333       300  

Provincial mining taxes

      110       97       200       165  

Share-based compensation (recovery) expense

      (41     49       75       91  

Foreign exchange loss, net of related derivatives

      13       22       16       29  

Other expenses

    3       222       126       336       194  

Earnings Before Finance Costs and Income Taxes

 

    1,777       1,782       2,137       2,008  

Finance costs

            173       155       349       334  

Earnings Before Income Taxes

      1,604       1,627       1,788       1,674  

Income tax expense

    4       382       398       427       426  

Net Earnings

            1,222       1,229       1,361       1,248  

Attributable to

         

Equity holders of Nutrien

      1,214       1,221       1,345       1,232  

Non-controlling interest

            8       8       16       16  

Net Earnings

            1,222       1,229       1,361       1,248  

Net Earnings Per Share Attributable to Equity Holders of Nutrien (“EPS”)

 

               

Basic

      2.53       2.51       2.80       2.52  

Diluted

            2.53       2.50       2.80       2.52  

Weighted average shares outstanding for basic EPS

      479,600,000       487,396,000       480,426,000       488,391,000  

Weighted average shares outstanding for diluted EPS

            479,824,000       487,598,000       480,725,000       488,563,000  
Condensed Consolidated Statements of Comprehensive Income

 

         

Three Months Ended
June 30

   

Six Months Ended
June 30

 
 ($ millions, net of related income taxes)          2026     2025     2026     2025  

Net Earnings

      1,222       1,229       1,361       1,248  

Other comprehensive (loss) income

         

Items that will not be reclassified to net earnings:

         

Net fair value loss on investments

      (10     -       (10     (18

Items that have been or may be subsequently reclassified to net earnings:

         

(Loss) gain on currency translation of foreign operations

      (11     162       61       201  

Other

            (9     22       (15     26  

Other Comprehensive (Loss) Income

            (30     184       36       209  

Comprehensive Income

            1,192       1,413       1,397       1,457  

Attributable to

         

Equity holders of Nutrien

      1,184       1,404       1,380       1,440  

Non-controlling interest

            8       9       17       17  

Comprehensive Income

            1,192       1,413       1,397       1,457  

(See Notes to the Condensed Consolidated Financial Statements)

 

23


Unaudited

 

Condensed Consolidated Statements of Cash Flows

 

          

Three Months Ended
June 30

   

Six Months Ended
June 30

 
 ($ millions)    Note     2026     2025     2026     2025  

Operating Activities

          

Net earnings

       1,222       1,229       1,361       1,248  

Adjustments for:

          

Depreciation and amortization

       604       614       1,210       1,185  

Share-based compensation (recovery) expense

       (41     49       75       91  

(Recovery of) provision for deferred income tax

       (17     (48     24       32  

Net (undistributed) distributed earnings of equity-accounted investees

       (1     90       (2     85  

Long-term income tax receivables and payables

       1       54       (14     16  

Other long-term assets, liabilities and miscellaneous

             70       (37     97       (32

Cash from operations before working capital changes

       1,838       1,951       2,751       2,625  

Changes in non-cash operating working capital:

          

Receivables

       (2,385     (2,462     (2,915     (2,605

Inventories and prepaid expenses and other current assets

       2,909       2,894       1,918       1,620  

Trade, other payables and accrued liabilities

             122       155       (121     (184

Cash Provided by Operating Activities

             2,484       2,538       1,633       1,456  

Investing Activities

          

Capital expenditures1

       (491     (424     (816     (724

Business acquisitions, net of cash acquired

       10       -       (40     (11

Purchase of investments, held within three months, net

       (33     (53     (41     (69

Purchase of investments

       (1     (91     (1     (93

Proceeds from sale of investments

       -       93       -       276  

Net changes in non-cash working capital

       16       10       (78     (78

Other

             (6     (30     (16     (39

Cash Used in Investing Activities

             (505     (495     (992     (738

Financing Activities

          

(Repayment of) proceeds from debt, maturing within three months, net

       (2,239     (578     (318     334  

Proceeds from debt

     6       1,000       -       1,000       998  

Repayment of debt

       (36     (531     (45     (535

Repayment of principal portion of lease liabilities

       (108     (106     (208     (216

Dividends paid to Nutrien’s shareholders

     7       (266     (268     (528     (533

Repurchase of common shares

     7       (173     (105     (320     (253

Issuance of common shares

       2       26       47       29  

Other

             (2     (10     (24     (31

Cash Used in Financing Activities

             (1,822     (1,572     (396     (207

Effect of Exchange Rate Changes on Cash and Cash Equivalents

             (13     21       (12     23  

Increase in Cash and Cash Equivalents

             144       492       233       534  

January 1, 2026 opening balance prior to restatement for amendments to IFRS 9

     9       -       -       701       -  

Adjustment on initial application of amendments to IFRS 9 on January 1, 2026

     9       -       -       (13     -  

Cash and Cash Equivalents – Beginning of Period

             777           895       688           853  

Cash and Cash Equivalents – End of Period

                 921       1,387           921       1,387  

Cash and cash equivalents is composed of:

          

Cash

       726       1,228       726       1,228  

Short-term investments

             195       159       195       159  
               921       1,387       921       1,387  

Supplemental Cash Flows Information

          

Interest paid

       192       220       340       352  

Income taxes paid (received)

       87       (19     124       (12

Total cash outflow for leases

             159       139       296       289  

1 Includes additions to property, plant and equipment, and intangible assets for the three months ended June 30, 2026 of $469 million and $22 million (2025 – $398 million and $26 million), respectively, and for the six months ended June 30, 2026 of $768 million and $48 million (2025 – $677 million and $47 million), respectively.

(See Notes to the Condensed Consolidated Financial Statements)

 

24


Unaudited

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

                      Accumulated other comprehensive
(loss) income (“AOCI”)
                         
 ($ millions, inclusive of related tax, except as otherwise
 noted)
  Number of
common
shares
    Share
capital
    Contributed
surplus
    (Loss) gain
on currency
translation
of foreign
operations
    Other     Total
AOCI
    Retained
earnings
    Equity
holders
of
Nutrien
    Non-
controlling
interest
    Total
equity
 
             

Balance – December 31, 2024

    491,025,446       13,748       68       (537     22       (515     11,106       24,407       35       24,442  
             

Net earnings

    -       -       -       -       -       -       1,232       1,232       16       1,248  
             

Other comprehensive income

    -       -       -       200       8       208       -       208       1       209  
             

Shares repurchased for cancellation (Note 7)

    (4,741,786     (133     (10     -       -       -       (114     (257     -       (257
             

Dividends declared1

    -       -       -       -       -       -       (533     (533     -       (533
             

Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (21     (21
             

Effect of share-based compensation including issuance of common shares

    581,799       35       (3     -       -       -       -       32       -       32  
             

Transfer of net gain on sale of investment

    -       -       -       -       (27     (27     27       -       -       -  
             

Transfer of net loss on cash flow hedges

    -       -       -       -       1       1       -       1       -       1  
             

Other

    -       -       -       (2     -       (2     1       (1     -       (1
             

Balance – June 30, 2025

    486,865,459       13,650       55       (339     4       (335     11,719       25,089       31       25,120  
             

Balance – December 31, 2025

    481,962,233       13,519       57       (329     -       (329     12,076       25,323       42       25,365  
             

Net earnings

    -       -       -       -       -       -       1,345       1,345       16       1,361  
             

Other comprehensive income (loss)

    -       -       -       60       (25     35       -       35       1       36  
             

Shares repurchased for cancellation (Note 7)

    (4,576,390     (128     -       -       -       -       (199     (327     -       (327
             

Dividends declared1

    -       -       -       -       -       -       (529     (529     -       (529
             

Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (23     (23
             

Effect of share-based compensation including issuance of common shares

    906,954       55       (6     -       -       -       -       49       -       49  
             

Transfer of net loss on cash flow hedges

    -       -       -       -       5       5       -       5       -       5  
           

Other

    -       -       -       -       -       -       1       1       -       1  
           

Balance – June 30, 2026

    478,292,797       13,446       51       (269     (20     (289     12,694       25,902       36       25,938  

1 During the six months ended June 30, 2026, we declared dividends of $1.10 per share (2025 – $1.09 per share).

(See Notes to the Condensed Consolidated Financial Statements)

 

25


Unaudited

 

Condensed Consolidated Balance Sheets

 

         

As at June 30

          As at
December 31
 
 ($ millions)   

Note

       2026          2025            2025  

Assets

              

Current assets

              

Cash and cash equivalents

        921        1,387           701  

Receivables

  

8

     8,687        8,086           5,675  

Inventories

        6,164        5,576           6,977  

Prepaid expenses and other current assets

          395        566             1,396  
        16,167        15,615           14,749  

Non-current assets

              

Property, plant and equipment

        22,672        22,496           22,747  

Goodwill

        12,174        12,121           12,136  

Intangible assets

        1,565        1,745           1,667  

Investments

        137        407           144  

Other assets

          840        871             858  

Total Assets

          53,555        53,255             52,301  

Liabilities

              

Current liabilities

              

Short-term debt

  

6

     527        1,882           873  

Current portion of long-term debt

  

6

     1,434        538           513  

Current portion of lease liabilities

        366        363           346  

Trade, other payables and accrued liabilities

  

8

     9,296        8,991             9,309  
        11,623        11,774           11,041  

Non-current liabilities

              

Long-term debt

  

6

     9,427        9,867           9,350  

Lease liabilities

        974        988           937  

Deferred income tax liabilities

        3,687        3,512           3,666  

Pension and other post-retirement benefit liabilities

        214        232           221  

Asset retirement obligations and accrued environmental costs

        1,447        1,536           1,468  

Other non-current liabilities

          245        226             253  

Total Liabilities

          27,617        28,135             26,936  

Shareholders’ Equity

              

Share capital

  

7

     13,446        13,650           13,519  

Contributed surplus

        51        55           57  

Accumulated other comprehensive loss

        (289      (335         (329

Retained earnings

          12,694        11,719             12,076  

Equity holders of Nutrien

        25,902        25,089           25,323  

Non-controlling interest

          36        31             42  

Total Shareholders’ Equity

          25,938        25,120             25,365  

Total Liabilities and Shareholders’ Equity

          53,555        53,255             52,301  

(See Notes to the Condensed Consolidated Financial Statements)

 

26


Unaudited

 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Six Months Ended June 30, 2026

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2025 annual audited consolidated financial statements with the exception of the amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, which were adopted effective January 1, 2026 (refer to Note 9). These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2025 annual audited consolidated financial statements. These interim financial statements are presented in millions of US dollars, unless otherwise indicated, which is the functional currency of Nutrien and the majority of its subsidiaries.

Certain immaterial 2025 figures have been reclassified in Note 2 Segment information.

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on August 5, 2026.

Note 2 Segment information

We have four reportable operating segments: Retail, Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, Australia and South America. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution reported costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core businesses. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

Seasonality in our business results from increased demand for products during planting season. Crop input sales are generally higher in the spring and fall application seasons. Crop input inventories are normally accumulated leading up to each application season. Our cash collections generally occur after the application season is complete, while customer prepayments made to us are typically concentrated in December and January and inventory prepayments paid to our suppliers are typically concentrated in the period from November to January. Feed and industrial sales are more evenly distributed throughout the year.

 

27


Unaudited

 

In the fourth quarter of 2025, the Chief Operating Decision Maker (“CODM”) reassessed our product groupings and determined that the performance of our Purchase for Resale business should be evaluated as part of the Corporate and Others segment. It had previously been presented in our Nitrogen segment. The Purchase for Resale business focuses primarily on sales to international customers. Purchased product that remains in upstream is primarily purchases of inventory to satisfy sales contracts that we cannot fulfill with our manufactured products. The CODM concluded this change was appropriate based on the nature and strategic alignment of purchase for resale activities. Comparative amounts for the Corporate and Others and Nitrogen segments were reclassified. As a result of the reclassification, the Corporate and Others segment reflected the following increases and the Nitrogen segment reflected the corresponding decreases for the three and six months ended June 30, 2025.

 

($ millions)

    
Three Months Ended
June 30, 2025
 
 
    
Six Months Ended
June 30, 2025
 
 

Sales

     73        143  

Gross Margin

     3        7  

EBITDA

     2        5  

 

    Three Months Ended June 30, 2026  
    Downstream           Upstream and Midstream                    
 ($ millions)   Retail            Potash      Nitrogen     Phosphate     Corporate
 and Others
    Eliminations     Consolidated  

Sales  – third party

     8,270         1,055       959         441       87       -       10,812  

       – intersegment

    -               80       314       84       -       (478     -  

Sales  – total

    8,270         1,135       1,273       525       87       (478     10,812  

Freight, transportation and distribution1

    -               82       119       57       (1     (54     203  

Net sales

    8,270         1,053       1,154       468       88       (424     10,609  

Cost of goods sold

    6,224               446       611       493       88       (504     7,358  

Gross margin

    2,046         607       543       (25     -       80       3,251  

Selling expenses (recovery)

    998         2       6       2       -       (7     1,001  

General and administrative expenses

    55         4       7       3       100       -       169  

Provincial mining taxes

    -         110       -       -       -       -       110  

Share-based compensation recovery

    -         -       -       -       (41     -       (41

Foreign exchange loss, net of related derivatives

    -         -       -       -       13       -       13  

Other expenses

    45               14       45       16       87       15       222  

Earnings (loss) before finance costs and income taxes

    948         477       485       (46     (159     72       1,777  

Depreciation and amortization

    183               181       150       69       21       -       604  

EBITDA

    1,131         658       635       23       (138     72       2,381  

Share-based compensation recovery

    -         -       -       -       (41     -       (41

Foreign exchange loss, net of related derivatives

    -         -       -       -       13       -       13  

ARO/ERL related expenses for non-operating sites2 (Note 3)

    -         -       -       -       11       -       11  

Restructuring costs (Note 3)

    -               -       -       -       66       -       66  

Adjusted EBITDA

    1,131               658       635       23       (89     72       2,430  

1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

2 ARO/ERL refers to asset retirement obligations and accrued environmental costs.

 

28


Unaudited

 

    Three Months Ended June 30, 2025  
    Downstream           Upstream and Midstream                    
 ($ millions)   Retail            Potash     Nitrogen1     Phosphate     Corporate
and Others1
    Eliminations     Consolidated  

Sales  – third party

     7,959         992       1,031         382       74       -       10,438  

       – intersegment

    -               93       309       67       -       (469     -  

Sales  – total

    7,959         1,085       1,340       449       74       (469     10,438  

Freight, transportation and distribution2

    -               94       153       53       -       (60     240  

Net sales

    7,959         991       1,187       396       74       (409     10,198  

Cost of goods sold

    5,941               440       674       363       70       (465     7,023  

Gross margin

    2,018         551       513       33       4       56       3,175  

Selling expenses (recovery)

    948         2       7       1       (1     (6     951  

General and administrative expenses

    44         2       6       1       95       -       148  

Provincial mining taxes

    -         97       -       -       -       -       97  

Share-based compensation expense

    -         -       -       -       49       -       49  

Foreign exchange loss, net of related derivatives

    -         -       -       -       22       -       22  

Other expenses

    54               8       1       7       46       10       126  

Earnings (loss) before finance costs and income taxes

    972         442       499       24       (207     52       1,782  

Depreciation and amortization

    177               188       166       68       15       -       614  

EBITDA

    1,149         630       665       92       (192     52       2,396  

Share-based compensation expense

    -         -       -       -       49       -       49  

Foreign exchange loss, net of related derivatives

    -         -       -       -       22       -       22  

ARO/ERL related income for non-operating sites (Note 3)

    -         -       -       -       (2     -       (2

Restructuring costs (Note 3)

    -               -       -       -       21       -       21  

Adjusted EBITDA

    1,149               630       665       92       (102     52       2,486  

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

29


Unaudited

 

    Six Months Ended June 30, 2026  
    Downstream           Upstream and Midstream                    
 ($ millions)   Retail            Potash      Nitrogen     Phosphate     Corporate
 and Others
    Eliminations     Consolidated  

Sales  – third party

    11,910         2,021       1,843       919       165       -       16,858  

       – intersegment

    -               155       561       153       -       (869     -  

Sales  – total

    11,910         2,176       2,404       1,072       165       (869     16,858  

Freight, transportation and distribution1

    -               197       236       119       (1     (104     447  

Net sales

    11,910         1,979       2,168       953       166       (765     16,411  

Cost of goods sold

    9,064               868       1,258       982       152       (810     11,514  

Gross margin

    2,846         1,111       910       (29     14       45       4,897  

Selling expenses (recovery)

    1,796         5       12       4       (3     (14     1,800  

General and administrative expenses

    99         7       11       5       211       -       333  

Provincial mining taxes

    -         200       -       -       -       -       200  

Share-based compensation expense

    -         -       -       -       75       -       75  

Foreign exchange (gain) loss, net of related derivatives

    (2       -       -       -       18       -       16  

Other expenses

    81               40       72       23       97       23       336  

Earnings (loss) before finance costs and income taxes

    872         859       815       (61     (384     36       2,137  

Depreciation and amortization

    367               356       302       141       44       -       1,210  

EBITDA

    1,239         1,215       1,117       80       (340     36       3,347  

Share-based compensation expense

    -         -       -       -       75       -       75  

Foreign exchange loss, net of related derivatives

    -         -       -       -       18       -       18  

ARO/ERL related income for non-operating sites (Note 3)

    -         -       -       -       (17     -       (17

Restructuring costs (Note 3)

    -         -       -       -       82       -       82  

Impairment of assets recorded in other income and expenses (Note 3)

    -               21       -       -       9       -       30  

Adjusted EBITDA

    1,239               1,236       1,117       80       (173     36       3,535  

1 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

30


Unaudited

 

    Six Months Ended June 30, 2025  
    Downstream           Upstream and Midstream                    
 ($ millions)   Retail            Potash     Nitrogen1     Phosphate     Corporate
and Others1
    Eliminations     Consolidated  

Sales  – third party

    11,049         1,758       1,853         720       158       -       15,538  

       – intersegment

    -               188       491       134       -       (813     -  

Sales  – total

    11,049         1,946       2,344       854       158       (813     15,538  

Freight, transportation and distribution2

    -               211       272       98       1       (116     466  

Net sales

    11,049         1,735       2,072       756       157       (697     15,072  

Cost of goods sold

    8,345               820       1,272       724       139       (723     10,577  

Gross margin

    2,704         915       800       32       18       26       4,495  

Selling expenses (recovery)

    1,703         5       14       3       (4     (13     1,708  

General and administrative expenses

    88         4       11       3       194       -       300  

Provincial mining taxes

    -         165       -       -       -       -       165  

Share-based compensation expense

    -         -       -       -       91       -       91  

Foreign exchange loss, net of related derivatives

    -         -       -       -       29       -       29  

Other expenses

    79               10       13       13       64       15       194  

Earnings (loss) before finance costs and income taxes

    834         731       762       13       (356     24       2,008  

Depreciation and amortization

    361               345       308       140       31       -       1,185  

EBITDA

    1,195         1,076       1,070       153       (325     24       3,193  

Share-based compensation expense

    -         -       -       -       91       -       91  

Foreign exchange loss, net of related derivatives

    -         -       -       -       29       -       29  

ARO/ERL related expenses for non-operating sites (Note 3)

    -         -       -       -       3       -       3  

Restructuring costs (Note 3)

    -               -       -       -       22       -       22  

Adjusted EBITDA

    1,195               1,076       1,070       153       (180     24       3,338  

1 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

2 Potash freight, transportation and distribution costs only apply to our North American potash sales volumes.

 

31


Unaudited

 

   

Three Months Ended
June 30

   

Six Months Ended
June 30

 
 ($ millions)   2026     2025     2026     2025  

Retail sales by product line

       

Crop nutrients

    3,541       3,391       5,024       4,585  

Crop protection products

    2,755       2,666       3,892       3,638  

Seed

    1,278       1,278       1,840       1,810  

Services and other

    308       286       483       432  

Merchandise

    291       238       514       427  

Nutrien Financial

    145       135       225       205  

Nutrien Financial elimination1

    (48     (35     (68     (48
      8,270       7,959       11,910       11,049  

Potash sales by geography

       

Manufactured product

       

North America

    353       382       837       816  

Offshore2

    781       701       1,338       1,127  

Other potash and purchased products

    1       2       1       3  
      1,135       1,085       2,176       1,946  

Nitrogen sales by product line

       

Manufactured product

       

Ammonia

    289       359       456       599  

Urea and ESN®

    355       530       771       912  

Solutions, nitrates and sulfates

    492       430       908       751  

Other nitrogen and purchased products3

    137       21       269       82  
      1,273       1,340       2,404       2,344  

Phosphate sales by product line

       

Manufactured product

       

Fertilizer

    335       285       694       534  

Industrial and feed

    183       155       366       306  

Other phosphate and purchased products

    7       9              12              14  
            525             449       1,072       854  

1 Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2 Relates to Canpotex Limited (“Canpotex”) (see Note 8) and includes provisional pricing adjustments for the three months ended June 30, 2026 of $18 million (2025 – $27 million) and the six months ended June 30, 2026 of $15 million (2025 – $58 million).

3 Comparative figures have been reclassified for our Purchase for Resale business from Nitrogen to the Corporate and Others segment.

Note 3 Other expenses (income)

 

   

Three Months Ended
June 30

   

Six Months Ended
June 30

 
 ($ millions)   2026     2025     2026     2025  

Restructuring costs

           66              21              82              22  

Earnings of equity-accounted investees

    (4     (9     (6     (14

Bad debt expense

    34       38       49       57  

Project feasibility costs

    24       26       42       41  

Customer prepayment costs

    19       19       38       37  

Legal expenses

    12       5       17       7  

ARO/ERL related expenses (income) for non-operating sites

    11       (2     (17     3  

Impairment of assets

    -       -       30       -  

Other expenses

    60       28       101       41  
      222       126       336       194  

 

32


Unaudited

 

Note 4 Income taxes

 

   

Three Months Ended
June 30

   

Six Months Ended
June 30

 
 ($ millions, except as otherwise noted)   2026     2025     2026     2025  

Actual effective tax rate on earnings (%)

           23               23               24               24   

Actual effective tax rate including discrete items (%)

    24       24       24       25  

Discrete tax adjustments that impacted the tax rate1

    11       22       3       27  

1 Discrete tax adjustments arise from specific, significant or unusual events that are recognized in the period in which the event occurs, rather than being allocated across the year through the annual effective tax rate.

Note 5 Financial instruments

Our financial instruments carrying amounts are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $10,861 million and fair value of $10,400 million as at June 30, 2026. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 6 Debt

On May 29, 2026, we issued $1 billion of senior notes. The senior notes are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series of outstanding senior notes is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

 

 ($ millions, except as otherwise noted)   Rate of interest (%)     Maturity     Amount  

Senior notes issued in 2026

         4.850           May 29, 2031            500  

Senior notes issued in 2026

    5.350       May 29, 2036       500  
                      1,000  

During the six months ended June 30, 2026, we entered into a $69 million uncommitted revolving demand facility. As at June 30, 2026, there were no borrowings outstanding under this facility. We also extended the maturity of our accounts receivable purchase facility from March 6, 2026 to March 31, 2028.

Note 7 Share capital

Share repurchase programs

The following table summarizes our share repurchase activities during the periods indicated below:

 

   

Three Months Ended
June 30

   

Six Months Ended
June 30

 
 ($ millions, except as otherwise noted)   2026     2025     2026     2025  

Number of common shares repurchased for cancellation

    2,494,887        1,878,972        4,576,390        4,741,786   

Average price per share (US dollars)

    69.33       56.39       70.08       53.19  

Total cost, inclusive of tax

    179       108       327       257  

Subsequent to June 30, 2026, as of August 4, 2026, an additional 1,238,033 common shares were repurchased for cancellation at a cost of $82 million and an average price per share of $66.98.

Dividends declared

We declared a dividend per share of $0.55 (2025 – $0.545) during the three months ended June 30, 2026, payable on July 17, 2026 to shareholders of record on June 30, 2026.

 

33


Unaudited

 

Note 8 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the time product is loaded for shipping, at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended June 30, 2026 were $58 million (2025 – $20 million) and the six months ended June 30, 2026 were $122 million (2025 – $77 million).

 

 ($ millions)   As at
June 30, 2026
    As at
December 31, 2025
 

Receivables from Canpotex

    339       279  

Payables to Canpotex

    100       63  

Note 9 Accounting policies, estimates and judgments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments

Amendments to IFRS 9 and IFRS 7, Amendments to the Classification and Measurement of Financial Instruments, were adopted effective January 1, 2026, the required adoption date. The amendments clarified the timing of recognition and derecognition of financial assets and financial liabilities. The adoption resulted in a change in the accounting policy relating to the timing of the derecognition of certain financial assets and financial liabilities, such that derecognition now occurs upon settlement.

The amendments were applied retrospectively without restatement of prior periods in accordance with the transitional provisions other than, on initial adoption, there was an adjustment of $(13) million to opening cash and cash equivalents as at January 1, 2026, which has been reflected in the condensed consolidated statement of cash flows for the six months ended June 30, 2026.

 

34